首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 0 毫秒
1.
2.
3.
发病时间窗内采用静脉溶栓是治疗急性缺血性卒中的首选方法。然而对于大血管闭塞性 脑梗死,静脉溶栓血管再通率偏低,血管内治疗可提高血管再通率。本文主要对动脉溶栓及机械取 栓的研究进展进行综述,旨在指导未来的临床工作。  相似文献   

4.

Objective

To assess the long-term functional outcome of stroke in patients treated with mechanical thrombectomy (MT) performed during work hours (on-hours) versus after-hours, weekends, and official holidays (off-hours).

Methods

Data on all patients receiving MT at a comprehensive stroke center was collected between December 2014-December 2016. Our primary outcomes were the discharge and 90-day modified Rankin Scale (mRS). We developed propensity scores for off-hours treatment and used inverse probability of treatment weights to address confounding. We estimated logistic regression to assess the relationship between off-hours treatment and favorable patient outcomes. Independent variables include receiving thrombectomy during the off-hours, admission National Institute of Health Stroke Scale (NIHSS), door to groin time in minutes, age, and race.

Results

During the study period, 80 (41%) patients underwent thrombectomy during on-hours and 116 (59%) during off-hours. Mean age was 69.1 years for the on-hours group and 64.1 years for the off-hours group (P?=?.02). There were no statistically significant differences in median admission NIHSS, rate of alteplase administration, mean time from last known well to thrombectomy, rate of revascularization, and rate of hemorrhagic transformation between the 2 groups. Logistic regression analysis showed the probability of a favorable outcome at discharge (mRS ≤ 2) is 12.6 % lower for off-hours patients (P?=?.038, [95%CI ?.25 to ?.01]). For patients with a 90-day mRS (n?=?117), the probability of a favorable outcome was 18.7% lower for those treated during the off-hours (P?=?.029, [95%CI ?.36 to ?.02]).

Conclusions

There is a higher probability of a good functional outcome in acute ischemic stroke patients who receive MT when performed during regular work hours.  相似文献   

5.
6.
7.
Intravenous recombinant tissue-plasminogen-activator (rtPA) and mechanical-thrombectomy (MT) are currently the only approved treatments for acute ischemic stroke. Their effectiveness was demonstrated in several clinical trials, and is therefore standard of care. Pregnant women were not included in these studies and consequently the effectiveness and safety in this group are unclear. We present a rare case of a patient in the third-trimester of pregnancy that underwent MT. A 29-year-old woman of 39 weeks’ gestation presented with left facial-paresis, hemiparesis, and neglect. Her CT-Angiogram showed a large occlusive thrombus within the right M1-M2 segments. During pregnancy she had developed thrombocytopenia. There was initial treatment decision dilemma. In view of her history of thrombocytopenia, there was concern about administering rtPA due to the risk of bleeding. As the thrombus was large, rtPA may also be ineffective. MT was proposed by the Stroke Physician as the preferred treatment option. A concern from the Interventional-Radiologist was the risk of exposure to radiation and contrast agents. As the patient had a disabling stroke at a young age, decision was made to proceed with MT which started 141 minutes after symptom onset. The clot was aspirated without complications. Final check angiogram showed complete resolution of flow within the right middle cerebral artery territory. The patient underwent elective uncomplicated Caesarean-section 5 days later delivering a healthy new born. Severe stroke in pregnancy is rare, but has grave consequences for both mother and infant. Timely decision-making is crucial. Our case demonstrates that MT can be provided safely and effectively in the third trimester of pregnancy.  相似文献   

8.
9.

Background

Thrombectomy is the first choice for cardioembolism due to atrial fibrillation (AF), however, whether valvular AF and nonvalvular AF had different safety and functional outcomes has not been reported yet. We aimed to investigate the differences between patients with valvular AF and patients with nonvalvular AF on safety and functional outcomes in acute large artery occlusion undergoing thrombectomy.

Methods

Valvular AF refers to patients with mitral stenosis or artificial heart valves and valve repair. Rate of symptomatic intracerebral hemorrhage [sICH], modified Rankin Scale Score (mRS), and death at 90 days were compared between valvular AF and nonvalvular AF groups. Univariate and multivariable logistic regression was performed to identify the predictors for unfavorable functional outcome (mRS 3-6).

Results

18.8% (51/271) of AF were valvular AF. The valvular AF group had significantly higher proportion of mRS 0-2 (49% [25/51] versus 33.3% [73/219], P?=?.04) and less death (21.6% [11/51] versus 38.4% [84/219], P?=?.02) comparing with nonvalvular AF group. The rates of sICH between both groups were nonsignificantly different (21.5% [47/219] for nonvalvular AF versus 13.7% [7/51] for valvular AF, P?=?.46). Valvular AF was not an independent predictor for unfavorable functional outcome (odds ratio .67, 95% confidence interval: .24-1.84) with age, collateral flow, chronic heart failure, NIHSS at admission, recanalization status, glucose at admission, occlusion site, ASPECTS, and ICH as covariates.

Conclusions

Valvular AF and nonvalvular AF have similar safety and functional outcomes in patients with acute anterior circulation large artery occlusion undergoing thrombectomy.  相似文献   

10.
11.
目的 探讨应用支架样取栓装置对前循环大动脉闭塞所致急性缺血性卒中患者机械取栓治疗的临 床效果。 方法 连续纳入采用支架样取栓装置治疗的前循环急性颅内大动脉近端闭塞患者。分析纳入患 者的临床特征、影像学资料、治疗及术后90 d临床随访结果。以术后90 d改良Rankin量表(modified Rankin Scale,mRS)评分为主要指标评估治疗有效性,以症状性颅内出血率、术后90 d死亡率评估治疗 的安全性。 结果 共纳入30例患者,29例应用Solitaire,1例应用Trevo。平均年龄(65.97±11.67)岁。入院时美国 国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分中位数13.50(9.75, 18.00)。包括颈内动脉闭塞9例,大脑中动脉M1段闭塞20例,大脑前动脉A1段闭塞1例。术后90 d随访, 56.7%(17/30)患者预后良好(mRS评分0~2分)。术后发生症状性颅内出血率13.3%(4/30),术后 90 d死亡率20%(6/30)。 结论 支架样取栓装置在前循环大动脉闭塞性急性缺血性卒中取栓治疗中临床效果较好,其有效 性、安全性能够在真实世界中得到体现,是治疗急性颅内大动脉闭塞的有效方法。  相似文献   

12.
Objective: Stroke care in the US is increasingly regionalized. Many patients undergo interhospital transfer to access specialized, time-sensitive interventions such as mechanical thrombectomy. Methods: Using a stratified survey design of the US Nationwide Inpatient Sample (2009-2014) we examined trends in interhospital transfers for ischemic stroke resulting in mechanical thrombectomy. International Classification of Disease—Ninth Revision (ICD-9) codes were used to identify stroke admissions and inpatient procedures within endovascular-capable hospitals. Regression analysis was used to identify factors associated with patient outcomes. Results: From 2009-2014, 772,437 ischemic stroke admissions were identified. Stroke admissions that arrived via interhospital transfer increased from 12.5% to 16.8%, 2009-2014 (P-trend < .001). Transfers receiving thrombectomy increased from 4.0% to 5.2%, 2009-2014 (P-trend?=?.016), while those receiving tissue plasminogen activator increased from 16.0% to 20.0%, 2009-2014 (P-trend < .001). One in 4 patients receiving thrombectomy were transferred from another acute care facility (n?=?6,014 of 24,861). Compared to patients arriving via the hospital “front door” receiving mechanical thrombectomy, those arriving via transfer were more often from rural areas and received by teaching hospitals with greater frequency of thrombectomy. Those arriving via interhospital transfer undergoing thrombectomy had greater odds of symptomatic intracranial hemorrhage (adjusted odds ratio [AOR] 1.19, 95% CI: 1.01-1.42) versus “front door” arrivals. There were no differences in inpatient mortality (AOR 1.11, 95% CI: .93-1.33). Conclusions: From 2009 to 2014, interhospital stroke transfers to endovascular-capable hospitals increased by one-third. For every ~15 additional transfers over the time period one additional patient received thrombectomy. Optimization of transfers presents an opportunity to increase access to thrombectomy.  相似文献   

13.
14.
15.
刘颖  丁晶  汪昕 《中国卒中杂志》2021,16(10):1067-1074
血管内治疗是急性大血管闭塞性卒中的重要治疗手段。有研究表明,超过40%接受血管内 治疗的患者虽然术后血管造影显示闭塞的颅内动脉已实现再通,但不能获得90 d功能独立,即无效再 通。无效再通严重影响血管内治疗的疗效,近年来逐渐引起临床重视。目前多项研究对无效再通的 相关机制及影响因素展开了探索,旨在寻找有效的干预措施,减少无效再通的发生,为改善血管内治 疗患者的预后提供依据。  相似文献   

16.

Background

The diffusion-weighted imaging (DWI) brain stem score (BSS) is an easy to use and can predict the clinical outcome of acute basilar artery occlusion (BAO) who underwent endovascular thrombectomy. The purpose of the current study was to validate its performance in Chinese acute BAO patients treated with mechanical thrombectomy.

Methods

Fifty consecutive patients with acute BAO who received early magnetic resonance imaging and treated with mechanical thrombectomy in a single-center were included. Early ischemic damage on DWI was evaluated by applying BSS system. Receiver operating characteristic (ROC) curve analysis was used to evaluate the performance of the score system and multivariate logistic regression analysis was performed to identify predictor of clinical outcome.

Results

Favorable outcomes were achieved in 38% patients (19 of 50 patients). Recanalization was successful in 92% patients (46 of 50 patients). Mortality rate was 26% (n?=?13/50). In ROC curve analysis, the area under ROC curve of BSS .864 (95% confidence interval [CI], .738-.945) to predict favorable and .769 (95% CI, .628-.877) to predictor mortality. In logistic regression adjusted for age, baseline National Institute of Health Stroke Scale and time to puncture, DWI BSS ≤2 (odds ratio [OR], 12.416; 95% CI, 2.520-61.179; P?=?.002) and DWI BSS >3 (OR, 7.871; 95% CI, 1.353-45.797; P?=?.022) were the independent predictor for favorable outcome and mortality at 3 months respectively.

Conclusions

The results of this study suggest that the DWI BSS can be used to predict clinical outcome in patients with acute BAO treated with mechanical thrombectomy at 3 months.  相似文献   

17.
18.
19.
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号